PROCEPT BioRobotics (PRCT) Change in Accured Expenses (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Change in Accured Expenses data on file, last reported at -$4.7 million in Q1 2026.

• On a quarterly basis, Change in Accured Expenses rose 28.55% year-over-year to -$4.7 million in Q1 2026; TTM through Mar 2026 was $2.0 million, a 131.2% increase from a year earlier, with the FY2025 full-year figure at $142000.0, up 5.97% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$4.7 million, down from -$65000.0 in the prior quarter.
• Over the last five years, Change in Accured Expenses for PRCT reached as high as $8.1 million in Q2 2025 and fell as low as -$6.6 million in Q1 2025.
• Historically, Change in Accured Expenses has averaged $352823.5 across 5 years, with a median of $346000.0 in 2023.
• On a YoY basis, Change in Accured Expenses climbed as much as 480.56% in 2025 and fell as far as 20603.12% in 2025.
• Year by year, Change in Accured Expenses stood at $5.7 million in 2022, then plunged by 44.81% to $3.1 million in 2023, then plunged by 158.19% to -$1.8 million in 2024, then surged by 96.42% to -$65000.0 in 2025, then sank by 7112.31% to -$4.7 million in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were -$4.7 million in Q1 2026, -$65000.0 in Q4 2025, and -$1.4 million in Q3 2025.